Literature DB >> 25728415

Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.

N Wohner1, P Legendre, C Casari, O D Christophe, P J Lenting, C V Denis.   

Abstract

BACKGROUND: von Willebrand factor (VWF) is cleared in a shear stress- and macrophage-dependent manner by LRP1. von Willebrand disease (VWD)-type 2B mutants are endocytosed more efficiently than wild-type (wt)-VWF by macrophages.
OBJECTIVE: To investigate if VWD-type 2B mutations in the VWF A1-domain affect LRP1 binding and LRP1-dependent clearance.
METHODS: Recombinant Fc-tagged A1 domain (A1-Fc, A2-Fc, A3-Fc) and full-length VWF (wt or mutants thereof) were tested for binding to LRP1 or a recombinant fragment thereof in a static immunosorbent assay. Mutant and wt-VWF were also compared for clearance in mice lacking macrophage LRP1 (macLRP1(-) ) and control mice (macLRP1(+) ).
RESULTS: We found that A1-Fc but not A2-Fc or A3-Fc binds dose-dependently to LRP1. Binding of A1-Fc to LRP1 was markedly enhanced by the VWD-type 2B mutation p.V1316M. As expected, full-length wt-VWF was unable to bind LRP1 under static conditions unless ristocetin was added. In contrast, the presence of the p.V1316M or p.R1306Q mutation induced spontaneous binding to LRP1 without the need for ristocetin or shear stress. Both mutants were cleared more rapidly than wt-VWF in control macLRP1(+) mice. Surprisingly, deletion of macrophage LRP1 abrogated the increased clearance of the VWF/p.R1306Q and VWF/p.V1316M mutant.
CONCLUSION: The VWF A1-domain contains a binding site for LRP1. Certain VWD-type 2B mutations relieve the need for shear stress to induce LRP1 binding. Enhanced LRP1 binding coincides with a reduced survival of VWF/p.R1306Q and VWF/p.V1316M. Our data provide a rationale for reduced VWF levels in at least some VWD-type 2B patients.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  LDL-receptor related proteins; half-life; protein-protein interaction domains; von Willebrand disease; von Willebrand factor

Mesh:

Substances:

Year:  2015        PMID: 25728415     DOI: 10.1111/jth.12885

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

2.  Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.

Authors:  Alexander Tischer; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Matthew Auton
Journal:  J Thromb Haemost       Date:  2019-09-03       Impact factor: 5.824

3.  Evidence That Factor VIII Forms a Bivalent Complex with the Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1): IDENTIFICATION OF CLUSTER IV ON LRP1 AS THE MAJOR BINDING SITE.

Authors:  Patricia A Young; Mary Migliorini; Dudley K Strickland
Journal:  J Biol Chem       Date:  2016-10-29       Impact factor: 5.157

Review 4.  New treatment approaches to von Willebrand disease.

Authors:  Michelle Lavin; James S O'Donnell
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Phospholipid-polymer amphiphile hybrid assemblies and their interaction with macrophages.

Authors:  Karthiga Panneerselvam; Martin E Lynge; Camilla Frich Riber; Sofia Mena-Hernando; Anton A A Smith; Kenneth N Goldie; Alexander N Zelikin; Brigitte Städler
Journal:  Biomicrofluidics       Date:  2015-08-24       Impact factor: 2.800

6.  Endocytosis by macrophages: interplay of macrophage scavenger receptor-1 and LDL receptor-related protein-1.

Authors:  Eelke P Béguin; Małgorzata A Przeradzka; Esmée F J Janssen; Henriët Meems; Magdalena Sedek; Carmen van der Zwaan; Koen Mertens; Maartje van den Biggelaar; Alexander B Meijer; Marjon J Mourik
Journal:  Haematologica       Date:  2019-06-27       Impact factor: 9.941

7.  Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor.

Authors:  Nikolett Wohner; Vincent Muczynski; Amel Mohamadi; Paulette Legendre; Valérie Proulle; Gabriel Aymé; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Caterina Casari
Journal:  Haematologica       Date:  2018-01-11       Impact factor: 9.941

8.  The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms.

Authors:  Monica Sacco; Stefano Lancellotti; Alessio Branchini; Maira Tardugno; Maria Francesca Testa; Barbara Lunghi; Francesco Bernardi; Mirko Pinotti; Betti Giusti; Giancarlo Castaman; Raimondo De Cristofaro
Journal:  J Thromb Haemost       Date:  2022-06-09       Impact factor: 16.036

9.  Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.

Authors:  Soracha E Ward; Jamie M O'Sullivan; Alan B Moran; Daniel I R Spencer; Richard A Gardner; Jyotika Sharma; Judicael Fazavana; Marco Monopoli; Thomas A J McKinnon; Alain Chion; Sandra Haberichter; James S O'Donnell
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.